Osteosarcoma Market to Grow Rapidly by 2032, Assesses DelveInsight | Leading Companies - MedPacto, Y-mAbs, QSAM, BioEclipse, Cellectar Biosciences, BioAtla, Salarius, Jazz, Fusion, Sumitomo Pharma Oncology
20 sept. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Osteosarcoma Market to Grow Rapidly by 2032, Assesses DelveInsight | Leading Companies - MedPacto, Y-mAbs, QSAM, BioEclipse, Cellectar Biosciences,...
Global Osteosarcoma Market Pipeline Report 2022: 131 Drugs in the Pipeline with 98% Molecules Present in Early-to-Mid Stage
21 avr. 2022 07h58 HE
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027" report has been added to...